IDIOPATHIC HYPERSOMNIA
Clinical trials for IDIOPATHIC HYPERSOMNIA explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC HYPERSOMNIA trials appear
Sign up with your email to follow new studies for IDIOPATHIC HYPERSOMNIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for chronic sleepiness in rare disorder
Disease control CompletedThis study looked at the long-term safety and effectiveness of pitolisant for adults with idiopathic hypersomnia, a condition causing severe daytime sleepiness. Participants had already completed a previous study of the same drug. The goal was to see if pitolisant remains safe an…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated May 17, 2026 08:55 UTC
-
New nightly pill aims to ease excessive daytime sleepiness
Symptom relief CompletedThis study tested a new once-nightly medication called FT218 in 157 people with idiopathic hypersomnia, a condition causing severe daytime sleepiness despite long sleep. The goal was to see if FT218 improves wakefulness and reduces symptoms compared to a placebo. Participants cou…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: PHASE3 • Sponsor: Avadel • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
New website aims to boost social lives of teens with rare sleep disorders
Knowledge-focused CompletedThis study tested a new website designed to help teenagers with narcolepsy or idiopathic hypersomnia improve their social relationships. Researchers asked 25 teens and their parents to review the website and give feedback through surveys. The goal was to see if the website was ea…
Matched conditions: IDIOPATHIC HYPERSOMNIA
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 08:52 UTC